Inhibition of caspase activity prevents CD95‐mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity
暂无分享,去创建一个
[1] W. Fiers,et al. Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways , 1998, The Journal of experimental medicine.
[2] H. Jaeschke,et al. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and fas‐antibody–induced liver injury , 1998, Hepatology.
[3] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[4] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[5] V. L. Johnson,et al. Fas‐mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases , 1998, Hepatology.
[6] N. Hayashi,et al. Delayed fas‐mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNFα , 1998, Hepatology.
[7] R. Bentley,et al. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation , 1998, Hepatology.
[8] J. Tschopp,et al. Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity , 1998, The Journal of experimental medicine.
[9] L. Moldawer,et al. Disparate Roles for TNF-α and Fas Ligand in Concanavalin A-Induced Hepatitis , 1998, The Journal of Immunology.
[10] A. Suzuki. The Dominant Role of CPP32 Subfamily in Fas-Mediated Hepatitis , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[11] H. Jaeschke,et al. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. , 1998, Journal of immunology.
[12] S. Yonehara,et al. Caspases Are Activated in a Branched Protease Cascade and Control Distinct Downstream Processes in Fas-induced Apoptosis , 1998, The Journal of experimental medicine.
[13] P. Galle,et al. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications. , 1998, Molecular medicine today.
[14] D. Häussinger,et al. Regulation of CD95 (APO‐1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells , 1998, Hepatology.
[15] P. Galle,et al. CD95-induced apoptosis in human liver disease. , 1998, Seminars in liver disease (Print).
[16] M. Leist,et al. Cytokine-mediated hepatic apoptosis. , 1998, Reviews of physiology, biochemistry and pharmacology.
[17] T. Hartung,et al. Immunomodulatory action of G‐CSF In a rat model of endotoxin‐induced liver injury: an intravital microscopic analysis of Kupffer cell and leukocyte response , 1997, Journal of leukocyte biology.
[18] W. Earnshaw,et al. Caspases and caspase inhibitors. , 1997, Trends in biochemical sciences.
[19] J. Fung,et al. Liver transplantation for acute liver failure: outcome analysis , 1997, Journal of viral hepatitis.
[20] G M Cohen,et al. Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.
[21] Matthias Mann,et al. FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC) , 1997, The EMBO journal.
[22] S. Nagata,et al. Essential roles of the Fas ligand in the development of hepatitis , 1997, Nature Medicine.
[23] K. Wilson,et al. Substrate and Inhibitor Specificity of Interleukin-1β-converting Enzyme and Related Caspases* , 1997, The Journal of Biological Chemistry.
[24] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[25] D. H. Burgess,et al. Involvement of cellular proteolytic machinery in apoptosis. , 1997, Biochemical and biophysical research communications.
[26] G. Feldmann. Liver apoptosis. , 1997, Journal of hepatology.
[27] G. Wanner,et al. MODULATION OF KUPFFER CELL ACTIVITY BY GADOLINIUM CHLORIDE IN ENDOTOXEMIC RATS , 1996, Shock.
[28] P. Henkart,et al. Different Interleukin-1β Converting Enzyme (ICE) Family Protease Requirements for the Apoptotic Death of T Lymphocytes Triggered by Diverse Stimuli , 1996, The Journal of experimental medicine.
[29] R. Williams,et al. Classification, Etiology, and Considerations of Outcome in Acute Liver Failure , 1996, Seminars in liver disease.
[30] S. Nagata,et al. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death , 1996, The Journal of experimental medicine.
[31] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.
[32] A. Chinnaiyan,et al. FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.
[33] D. Nicholson. ICE/CED3-like Proteases as Therapeutic Targets for the Control of Inappropriate Apoptosis , 1996, Nature Biotechnology.
[34] M. Clemens,et al. Chronic ethanol consumption exacerbates liver injury following hemorrhagic shock: role of sinusoidal perfusion failure. , 1995, Shock.
[35] H. Fusamoto,et al. Apoptosis: A new mechanism of endothelial and Kupffer cell killing , 1995, Journal of gastroenterology and hepatology.
[36] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[37] M. Leist,et al. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. , 1995, The American journal of pathology.
[38] G. Fiucci,et al. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. , 1995, Journal of immunology.
[39] E. Deitch,et al. Multiple organ failure: a common problem in surgical intensive care unit patients. , 1995, Annals of medicine.
[40] A. Baue. Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome-where do we stand? , 1994, Shock.
[41] S. Nagata,et al. Fas-mediated apoptosis in primary cultured mouse hepatocytes. , 1994, Experimental cell research.
[42] Matthew J. Brauer,et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.
[43] N. Thornberry. Interleukin-1 beta converting enzyme. , 1994, Methods in enzymology.
[44] L. A. Reiter,et al. Interleukin-1 beta converting enzyme. Synthesis of hydroxyethyl dipeptide surrogate-containing compounds as potential ICE inhibitors. , 2009, International journal of peptide and protein research.
[45] E. Schmidt,et al. Organization and Flow in the Liver Microcirculation1 , 1993 .
[46] Gwyn T. Williams,et al. Molecular regulation of apoptosis: Genetic controls on cell death , 1993, Cell.
[47] S. Nagata,et al. Lethal effect of the anti-Fas antibody in mice , 1993, Nature.
[48] K. Messmer,et al. Microcirculatory Manifestations of Hepatic Ischemia/Reperfusion Injury1 , 1993 .
[49] M. Menger,et al. Assessment of hepatic phagocytic activity by in vivo microscopy after liver transplantation in the rat , 1992, Hepatology.
[50] E. Deitch,et al. Multiple organ failure. Pathophysiology and potential future therapy. , 1992, Annals of surgery.
[51] M. Raff,et al. Social controls on cell survival and cell death , 1992, Nature.
[52] N. Copeland,et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. , 1992, Journal of immunology.
[53] A. Wyllie,et al. Cell death: the significance of apoptosis. , 1980, International review of cytology.
[54] B Eiseman,et al. Multiple organ failure. , 1977, Surgery, gynecology & obstetrics.